Remed Co

Remed Co ROIC

The Return on Invested Capital (ROIC) of Remed Co (302550.KQ) as of Oct 28, 2026 is 1.23 %. In the previous year, Return on Invested Capital (ROIC) was 15.00 % — a change of -91.80% (lower).

ROIC

1.23 %

YoY

-91.80%

Last updated:

Return on Invested Capital (ROIC) of Remed Co is 2025 1.23 % . Return on Invested Capital (ROIC) of Remed Co was 2024 15.00 % . It decreases by -91.80% lower compared to the previous year.

The Remed Co ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
-42.03 KRW
Jan 1, 2019
14.31 KRW
Jan 1, 2020
-4.20 KRW
Jan 1, 2021
1.65 KRW
Jan 1, 2022
11.43 KRW
Jan 1, 2023
1.65 KRW
Jan 1, 2024
15.00 KRW
Jan 1, 2025
1.23 KRW
The Remed Co ROIC history
YEARROICYoY
1.23 %-91.80%
15.00 %+811.49%
1.65 %-85.61%
11.43 %+593.96%
1.65 %-139.24%
-4.20 %-129.33%
14.31 %-134.06%
-42.03 %-10,233.59%
0.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Remed Co Stock analysis

What does Remed Co do? REMED Co., Ltd. generates revenue through the manufacturing and sale of medical equipment, including transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, and biosignal and monitoring machines. Pain therapy machines encompass electromagnetic stimulation machines, extracorporeal shockwave therapy machines, and high intensity laser therapy machines. Biosignal and monitoring machines include patient monitors, fetal monitors, and electrocardiogram (ECG/EKG) machines. The company distributes these products domestically and internationally, targeting healthcare providers and medical facilities that require specialized therapeutic and monitoring solutions. The firm's product portfolio focuses on advanced medical devices for neurological and pain management, as well as patient monitoring. Transcranial magnetic stimulation (TMS) therapy machines are used for neurological treatments, while pain therapy machines address chronic pain conditions. Biosignal and monitoring machines support critical patient care, with electrocardiogram (ECG/EKG) machines being a key component. These products are sold to hospitals, clinics, and medical centers across domestic and overseas markets. REMED Co., Ltd. serves healthcare institutions that require specialized equipment for diagnosis, treatment, and monitoring. The domestic market includes hospitals and clinics in Daejeon, while overseas markets extend to international healthcare providers. The company’s revenue streams are derived from direct sales of its medical equipment, with no mention of additional services or licensing agreements in the business description. Remed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remed Co stock

Return on Invested Capital (ROIC) of Remed Co is 1.23 % in 2025.

Return on Invested Capital (ROIC) of Remed Co changed from 15.00 % to 1.23 %, representing a -91.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Remed Co since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Remed Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Remed Co

All Key Metrics — Remed Co